GE HealthCare Technologies Inc

We exclude from Segment EBIT certain corporate-related expenses and certain transactions or adjustments that our Chief Operating Decision Maker (which is our Chief Executive Officer) considers to be non-operational, such as Interest and other financial charges – net, Benefit (provision) for income taxes, Restructuring costs, Acquisition and disposition-related benefits (charges), Spin-Off and separation costs, Non-operating benefit (income) costs, Gain (loss) on business and asset dispositions, Amortization of acquisition-related intangible assets, Net (income) loss attributable to noncontrolling interests, Income (loss) from discontinued operations, net of taxes, and Investment revaluation gain (loss). See “Results of Operations” section above for discussion on the performance of segments on revenue.

(1)For additional details regarding Segment EBIT, see Note 3, “Segment Information.”

•Imaging Segment EBIT was $240 million, an increase of $49 million due to cost productivity and an increase in price, partially offset by cost inflation;

•Ultrasound Segment EBIT was $182 million, a decrease of $25 million due to cost inflation and a decrease in sales volume, partially offset by cost productivity;

•PCS Segment EBIT was $81 million, a decrease of $28 million due to cost inflation and a decrease in sales volume, partially offset by cost productivity; and

•PDx Segment EBIT was $178 million, an increase of $23 million due to an increase in price, cost productivity, and an increase in volume, partially offset by investments.